MX1 and bacterial infectious disease: FebriDx provides qualitative results for elevated serum levels of c-reactive protein (CRP), an acute phase reactant associated with bacterial infection, and myxovirus resistance protein A (MxA), which is a derivative of interferonα/β associated with viral infection [8,9].